Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Mohamed-Ali

Showing results (11-20 of 56) with videos related to

Pageof 6
Sort By:
Journal of Periodontal Research|August 25, 2004
Periodontal therapy: a novel non-drug-induced experimental model to study human inflammationF D'Aiuto, L Nibali, V Mohamed-Ali, et al.
Clinical Drug Investigation|March 29, 2008
Effects of Glimepiride vs Glibenclamide on Ischaemic Heart Disease Risk Factors and Glycaemic Control in Patients with Type 2 Diabetes MellitusM E Britton, A E Denver, V Mohamed-Ali, et al.
Thrombosis Research|November 30, 1999
Lack of evidence for secretion of plasminogen activator inhibitor-1 by human subcutaneous adipose tissue in vivoJ S Yudkin, S W Coppack, K Bulmer, et al.
Metabolism: Clinical and Experimental|June 17, 1998
Effect of insulin versus sulfonylurea therapy on cardiovascular risk factors and fibrinolysis in type II diabetesA Panahloo, V Mohamed-Ali, C Andrés, et al.
Journal of Internal Medicine|March 13, 2002
Evidence for the regulation of levels of plasma adhesion molecules by proinflammatory cytokines and their soluble receptors in type 1 diabetesV Mohamed-Ali, L Armstrong, D Clarke, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|January 1, 1996
Plasminogen activator inhibitor (PAI-1) activity is elevated in Asian and Caucasian subjects with non-insulin-dependent (type 2) diabetes but not in those with impaired glucose tolerance (IGT) or non-diabetic AsiansD K Nagi, V Mohamed Ali, S K Jain, et al.
Atherosclerosis|April 1, 1997
Proinsulin-like molecules and plasminogen activator inhibitor type 1 (PAI-1) activity in diabetic and non-diabetic subjects with and without myocardial infarctionR P Gray, A Panahloo, V Mohamed-Ali, et al.
Journal of Diabetes and Its Complications|October 1, 1995
Insulin resistance in non-insulin-dependent diabetes mellitus is associated with microalbuminuria independently of ambulatory blood pressureJ H Pinkney, A E Denver, V Mohamed-Ali, et al.
Diabetes Care|April 16, 1998
Intact proinsulin, des 31,32 proinsulin, and specific insulin concentrations among nondiabetic and diabetic subjects in populations at varying risk of type 2 diabetesD K Nagi, W C Knowler, V Mohamed-Ali, et al.
Journal of Diabetes and Its Complications|July 1, 1994
Associations of urinary albumin excretion rate with vascular disease in europid nondiabetic subjectsM M Gould, V Mohamed-Ali, S A Goubet, et al.
Pageof 6

Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
Journal of Periodontal Research|August 25, 2004
Periodontal therapy: a novel non-drug-induced experimental model to study human inflammationF D'Aiuto, L Nibali, V Mohamed-Ali, et al.
Clinical Drug Investigation|March 29, 2008
Effects of Glimepiride vs Glibenclamide on Ischaemic Heart Disease Risk Factors and Glycaemic Control in Patients with Type 2 Diabetes MellitusM E Britton, A E Denver, V Mohamed-Ali, et al.
Thrombosis Research|November 30, 1999
Lack of evidence for secretion of plasminogen activator inhibitor-1 by human subcutaneous adipose tissue in vivoJ S Yudkin, S W Coppack, K Bulmer, et al.
Metabolism: Clinical and Experimental|June 17, 1998
Effect of insulin versus sulfonylurea therapy on cardiovascular risk factors and fibrinolysis in type II diabetesA Panahloo, V Mohamed-Ali, C Andrés, et al.
Journal of Internal Medicine|March 13, 2002
Evidence for the regulation of levels of plasma adhesion molecules by proinflammatory cytokines and their soluble receptors in type 1 diabetesV Mohamed-Ali, L Armstrong, D Clarke, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|January 1, 1996
Plasminogen activator inhibitor (PAI-1) activity is elevated in Asian and Caucasian subjects with non-insulin-dependent (type 2) diabetes but not in those with impaired glucose tolerance (IGT) or non-diabetic AsiansD K Nagi, V Mohamed Ali, S K Jain, et al.
Atherosclerosis|April 1, 1997
Proinsulin-like molecules and plasminogen activator inhibitor type 1 (PAI-1) activity in diabetic and non-diabetic subjects with and without myocardial infarctionR P Gray, A Panahloo, V Mohamed-Ali, et al.
Journal of Diabetes and Its Complications|October 1, 1995
Insulin resistance in non-insulin-dependent diabetes mellitus is associated with microalbuminuria independently of ambulatory blood pressureJ H Pinkney, A E Denver, V Mohamed-Ali, et al.
Diabetes Care|April 16, 1998
Intact proinsulin, des 31,32 proinsulin, and specific insulin concentrations among nondiabetic and diabetic subjects in populations at varying risk of type 2 diabetesD K Nagi, W C Knowler, V Mohamed-Ali, et al.
Journal of Diabetes and Its Complications|July 1, 1994
Associations of urinary albumin excretion rate with vascular disease in europid nondiabetic subjectsM M Gould, V Mohamed-Ali, S A Goubet, et al.
Pageof 6